In AML cells with already activated p53 (cells treated with chemotherapy or cells with a high level of differentiation), it is possible that differentiation therapy could be sufficient to induce differentiation or apoptosis in a p53-dependent manner. Here, TP53 is linked to acute myeloid leukemia.